vs

Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Velocity Financial, Inc. (VEL). Click either name above to swap in a different company.

Velocity Financial, Inc. is the larger business by last-quarter revenue ($51.6M vs $44.9M, roughly 1.2× AbCellera Biologics Inc.). Velocity Financial, Inc. runs the higher net margin — 67.3% vs -19.9%, a 87.3% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 32.8%). Velocity Financial, Inc. produced more free cash flow last quarter ($17.9M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 32.3%).

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

Velocity Financial, Inc. is a U.S.-headquartered real estate finance company that offers specialized mortgage loan solutions primarily for residential investment properties. It partners with independent mortgage brokers nationwide, providing real estate investors with short-term bridge loans and long-term rental property financing options tailored to their operational needs.

ABCL vs VEL — Head-to-Head

Bigger by revenue
VEL
VEL
1.2× larger
VEL
$51.6M
$44.9M
ABCL
Growing faster (revenue YoY)
ABCL
ABCL
+755.6% gap
ABCL
788.4%
32.8%
VEL
Higher net margin
VEL
VEL
87.3% more per $
VEL
67.3%
-19.9%
ABCL
More free cash flow
VEL
VEL
$62.5M more FCF
VEL
$17.9M
$-44.6M
ABCL
Faster 2-yr revenue CAGR
ABCL
ABCL
Annualised
ABCL
112.3%
32.3%
VEL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ABCL
ABCL
VEL
VEL
Revenue
$44.9M
$51.6M
Net Profit
$-8.9M
$34.8M
Gross Margin
Operating Margin
-63.7%
97.0%
Net Margin
-19.9%
67.3%
Revenue YoY
788.4%
32.8%
Net Profit YoY
73.9%
67.0%
EPS (diluted)
$-0.03
$0.90

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABCL
ABCL
VEL
VEL
Q4 25
$44.9M
$51.6M
Q3 25
$9.0M
$49.1M
Q2 25
$17.1M
$47.6M
Q1 25
$4.2M
$37.5M
Q4 24
$5.0M
$38.9M
Q3 24
$6.5M
$35.1M
Q2 24
$7.3M
$32.4M
Q1 24
$10.0M
$29.5M
Net Profit
ABCL
ABCL
VEL
VEL
Q4 25
$-8.9M
$34.8M
Q3 25
$-57.1M
$25.4M
Q2 25
$-34.7M
$26.0M
Q1 25
$-45.6M
$18.9M
Q4 24
$20.8M
Q3 24
$-51.1M
$15.8M
Q2 24
$-36.9M
$14.8M
Q1 24
$-40.6M
$17.3M
Operating Margin
ABCL
ABCL
VEL
VEL
Q4 25
-63.7%
97.0%
Q3 25
-851.8%
72.1%
Q2 25
-290.2%
71.3%
Q1 25
-1479.6%
71.7%
Q4 24
82.5%
Q3 24
-1439.4%
60.6%
Q2 24
-1276.2%
61.3%
Q1 24
-551.5%
78.8%
Net Margin
ABCL
ABCL
VEL
VEL
Q4 25
-19.9%
67.3%
Q3 25
-637.8%
51.7%
Q2 25
-203.3%
54.6%
Q1 25
-1077.2%
50.4%
Q4 24
53.5%
Q3 24
-785.4%
45.1%
Q2 24
-504.3%
45.6%
Q1 24
-408.0%
58.5%
EPS (diluted)
ABCL
ABCL
VEL
VEL
Q4 25
$-0.03
$0.90
Q3 25
$-0.19
$0.65
Q2 25
$-0.12
$0.69
Q1 25
$-0.15
$0.51
Q4 24
$0.56
Q3 24
$-0.17
$0.44
Q2 24
$-0.13
$0.42
Q1 24
$-0.14
$0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABCL
ABCL
VEL
VEL
Cash + ST InvestmentsLiquidity on hand
$128.5M
$92.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$966.9M
$672.5M
Total Assets
$1.4B
$7.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABCL
ABCL
VEL
VEL
Q4 25
$128.5M
$92.1M
Q3 25
$83.2M
$99.0M
Q2 25
$92.4M
$79.6M
Q1 25
$159.3M
$51.7M
Q4 24
$156.3M
$49.9M
Q3 24
$126.6M
$44.1M
Q2 24
$148.3M
$47.4M
Q1 24
$123.6M
$34.8M
Stockholders' Equity
ABCL
ABCL
VEL
VEL
Q4 25
$966.9M
$672.5M
Q3 25
$964.0M
$634.3M
Q2 25
$1.0B
$597.9M
Q1 25
$1.0B
$563.2M
Q4 24
$1.1B
$516.9M
Q3 24
$1.1B
$484.6M
Q2 24
$1.1B
$471.3M
Q1 24
$1.1B
$452.9M
Total Assets
ABCL
ABCL
VEL
VEL
Q4 25
$1.4B
$7.4B
Q3 25
$1.4B
$7.0B
Q2 25
$1.4B
$6.5B
Q1 25
$1.3B
$6.0B
Q4 24
$1.4B
$5.5B
Q3 24
$1.4B
$5.2B
Q2 24
$1.4B
$4.9B
Q1 24
$1.5B
$4.6B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABCL
ABCL
VEL
VEL
Operating Cash FlowLast quarter
$-34.7M
$18.2M
Free Cash FlowOCF − Capex
$-44.6M
$17.9M
FCF MarginFCF / Revenue
-99.4%
34.6%
Capex IntensityCapex / Revenue
21.9%
0.5%
Cash ConversionOCF / Net Profit
0.52×
TTM Free Cash FlowTrailing 4 quarters
$-174.1M
$40.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABCL
ABCL
VEL
VEL
Q4 25
$-34.7M
$18.2M
Q3 25
$-52.6M
$11.5M
Q2 25
$-32.4M
$7.7M
Q1 25
$-11.6M
$3.5M
Q4 24
$-108.6M
$37.8M
Q3 24
$-28.9M
$-17.6M
Q2 24
$-30.0M
$11.5M
Q1 24
$-41.7M
$10.6M
Free Cash Flow
ABCL
ABCL
VEL
VEL
Q4 25
$-44.6M
$17.9M
Q3 25
$-61.5M
$11.4M
Q2 25
$-45.8M
$7.6M
Q1 25
$-22.2M
$3.5M
Q4 24
$-187.0M
$37.5M
Q3 24
$-47.4M
$-17.6M
Q2 24
$-50.1M
$11.4M
Q1 24
$-65.8M
$10.5M
FCF Margin
ABCL
ABCL
VEL
VEL
Q4 25
-99.4%
34.6%
Q3 25
-687.0%
23.2%
Q2 25
-267.9%
15.9%
Q1 25
-524.0%
9.2%
Q4 24
-3702.8%
96.4%
Q3 24
-728.4%
-50.3%
Q2 24
-683.8%
35.1%
Q1 24
-661.5%
35.8%
Capex Intensity
ABCL
ABCL
VEL
VEL
Q4 25
21.9%
0.5%
Q3 25
99.7%
0.1%
Q2 25
78.2%
0.2%
Q1 25
251.1%
0.2%
Q4 24
1552.7%
0.7%
Q3 24
284.6%
0.2%
Q2 24
274.6%
0.3%
Q1 24
242.5%
0.1%
Cash Conversion
ABCL
ABCL
VEL
VEL
Q4 25
0.52×
Q3 25
0.45×
Q2 25
0.29×
Q1 25
0.19×
Q4 24
1.81×
Q3 24
-1.11×
Q2 24
0.78×
Q1 24
0.61×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ABCL
ABCL

Segment breakdown not available.

VEL
VEL

Related Party$19.3M37%
Nonrelated Party$16.9M33%
Other$15.4M30%

Related Comparisons